BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sohn EY, Kato R, Noetzli LJ, Gera A, Coates T, Harmatz P, Keens TG, Wood JC. Exercise performance in thalassemia major: Correlation with cardiac iron burden. Am J Hematol 2013;88:193-7. [DOI: 10.1002/ajh.23370] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Buratti P, Gammella E, Rybinska I, Cairo G, Recalcati S. Recent Advances in Iron Metabolism: Relevance for Health, Exercise, and Performance. Med Sci Sports Exerc 2015;47:1596-604. [PMID: 25494391 DOI: 10.1249/MSS.0000000000000593] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
2 Georgakouli K, Stamperna A, Deli CK, Syrou N, Draganidis D, Fatouros IG, Jamurtas AZ. The Effects of Postprandial Resistance Exercise on Blood Glucose and Lipids in Prediabetic, Beta-Thalassemia Major Patients. Sports (Basel) 2020;8:E57. [PMID: 32357481 DOI: 10.3390/sports8050057] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Benedetto D, Rao CM, Cefalù C, Aguglia DO, Cattadori G, D'Ascola DG, Benedetto FA, Agostoni P, Sciomer S. Effects of blood transfusion on exercise capacity in thalassemia major patients. PLoS One 2015;10:e0127553. [PMID: 26010540 DOI: 10.1371/journal.pone.0127553] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
4 Hamed AA, Elguindy W, Elhenawy YI, Ibrahim RH. Early Cardiac Involvement and Risk Factors for the Development of Arrhythmia in Patients With β-Thalassemia Major. J Pediatr Hematol Oncol 2016;38:5-11. [PMID: 26583617 DOI: 10.1097/MPH.0000000000000467] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Origa R, Baldan A, Marsella M, Borgna-Pignatti C. A complicated disease: what can be done to manage thalassemia major more effectively? Expert Rev Hematol 2015;8:851-62. [PMID: 26470003 DOI: 10.1586/17474086.2015.1101339] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Matza LS, Paramore LC, Stewart KD, Karn H, Jobanputra M, Dietz AC. Health state utilities associated with treatment for transfusion-dependent β-thalassemia. Eur J Health Econ 2020;21:397-407. [PMID: 31828456 DOI: 10.1007/s10198-019-01136-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Meloni A, Detterich J, Pepe A, Harmatz P, Coates TD, Wood JC. Pulmonary hypertension in well-transfused thalassemia major patients. Blood Cells Mol Dis. 2015;54:189-194. [PMID: 25488617 DOI: 10.1016/j.bcmd.2014.11.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
8 Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, Hoffman TM, Kiernan MS, Lerakis S, Piga A. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013;128:281-308. [PMID: 23775258 DOI: 10.1161/cir.0b013e31829b2be6] [Cited by in Crossref: 187] [Cited by in F6Publishing: 71] [Article Influence: 20.8] [Reference Citation Analysis]
9 Piatti G, Giuditta M, Pierini A, Consonni D, Cassinerio E, Cappellini MD. Muscular de-conditioning and reduced cardiac inotropism due to iron deposition reduce exercise tolerance in beta thalassemia major. Am J Hematol 2021;96:E370-3. [PMID: 34152635 DOI: 10.1002/ajh.26278] [Reference Citation Analysis]
10 Kostopoulou AG, Tsiapras DP, Chaidaroglou AS, De giannis DE, Farmakis D, Kremastinos DT. The pathophysiological relationship and clinical significance of left atrial function and left ventricular diastolic dysfunction in β-thalassemia major. Am J Hematol 2014;89:13-8. [DOI: 10.1002/ajh.23581] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]